MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR - Scorecard - MDSpire
Advertisement
MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR
Clinical Scorecard: The Relationship Between MAFLD and Reduced Bone Mineral Density in Type 2 Diabetes Patients: An Exploratory Cross-Sectional Study Examining the Role of HOMA-IR as a Potential Mediator
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Care Setting
Retrospective cross-sectional study in a hospital setting
Key Highlights
Insulin resistance (HOMA-IR) accounts for a small indirect effect on BMD (β = -0.070, 95% CI: -0.142 to -0.015).
Guideline-Based Recommendations
Diagnosis
Management
Consider pharmacological interventions for osteoporosis in high-risk patients.
Monitoring & Follow-up
Regular BMD assessments for T2DM patients with MAFLD.
Risks
Patient & Prescribing Data
169 patients with T2DM, including 108 men and 61 women.
Study suggests a need for monitoring bone health in T2DM patients with MAFLD.
Clinical Best Practices
Encourage lifestyle modifications to improve bone health.
